NeuroImage: Clinical (Jan 2021)
Disease-related cortical thinning in presymptomatic granulin mutation carriers
- Sergi Borrego-Écija,
- Roser Sala-Llonch,
- John van Swieten,
- Barbara Borroni,
- Fermín Moreno,
- Mario Masellis,
- Carmela Tartaglia,
- Caroline Graff,
- Daniela Galimberti,
- Robert Laforce, Jr,
- James B Rowe,
- Elizabeth Finger,
- Rik Vandenberghe,
- Fabrizio Tagliavini,
- Alexandre de Mendonça,
- Isabel Santana,
- Matthis Synofzik,
- Simon Ducharme,
- Johannes Levin,
- Adrian Danek,
- Alex Gerhard,
- Markus Otto,
- Chris Butler,
- Giovanni Frisoni,
- Sandro Sorbi,
- Carolin Heller,
- Martina Bocchetta,
- David M Cash,
- Rhian S Convery,
- Katrina M Moore,
- Jonathan D Rohrer,
- Raquel Sanchez-Valle,
- Martin N. Rossor,
- Nick C. Fox,
- Ione O.C. Woollacott,
- Rachelle Shafei,
- Caroline Greaves,
- Mollie Neason,
- Rita Guerreiro,
- Jose Bras,
- David L. Thomas,
- Jennifer Nicholas,
- Simon Mead,
- Lieke Meeter,
- Jessica Panman,
- Janne Papma,
- Rick van Minkelen,
- Yolande Pijnenburg,
- Begoña Indakoetxea,
- Alazne Gabilondo,
- Mikel TaintaMD,
- Maria de Arriba,
- Ana Gorostidi,
- Miren Zulaica,
- Jorge Villanua,
- Zigor Diaz,
- Jaume Olives,
- Albert Lladó,
- Mircea Balasa,
- Anna Antonell,
- Nuria Bargallo,
- Enrico Premi,
- Maura Cosseddu,
- Stefano Gazzina,
- Alessandro Padovani,
- Roberto Gasparotti,
- Silvana Archetti,
- Sandra Black,
- Sara Mitchell,
- Ekaterina Rogaeva,
- Morris Freedman,
- Ron Keren,
- David Tang-Wai,
- Linn Öijerstedt,
- Christin Andersson,
- Vesna Jelic,
- Hakan Thonberg,
- Andrea Arighi,
- Chiara Fenoglio,
- Elio Scarpini MD,
- Giorgio Fumagalli,
- Thomas Cope,
- Carolyn Timberlake,
- Timothy Rittman,
- Christen Shoesmith,
- Robart Bartha,
- Rosa Rademakers,
- Carlo Wilke,
- Benjamin Bender,
- Rose Bruffaerts,
- Philip Vandamme,
- Mathieu Vandenbulcke,
- Carolina Maruta,
- Catarina B. Ferreira,
- Gabriel Miltenberger,
- Ana Verdelho,
- Sónia Afonso,
- Ricardo Taipa,
- Paola Caroppo,
- Giuseppe Di Fede,
- Giorgio Giaccone,
- Sara Prioni,
- Veronica Redaelli,
- Giacomina Rossi,
- Pietro Tiraboschi,
- Diana Duro,
- Maria Rosario Almeida,
- Miguel Castelo-Branco,
- Maria João Leitão,
- Miguel Tabuas-Pereira,
- Beatriz Santiago,
- Serge Gauthier,
- Pedro Rosa-Neto,
- Michele Veldsman,
- Toby Flanagan,
- Catharina Prix,
- Tobias Hoegen,
- Elisabeth Wlasich,
- Sandra Loosli,
- Sonja Schonecker,
- Elisa Semler,
- Sarah Anderl-Straub
Affiliations
- Sergi Borrego-Écija
- Alzheimer’s disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain
- Roser Sala-Llonch
- Departament de Biomedicina, Institute of Neuroscience, University of Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain
- John van Swieten
- Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands
- Barbara Borroni
- Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
- Fermín Moreno
- Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain
- Mario Masellis
- LC Campbell Cognitive Neurology Research Unit, Sunnybrook Research Institute, University of Toronto, Toronto, Ontario, Canada
- Carmela Tartaglia
- Toronto Western Hospital, Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada
- Caroline Graff
- Department of Geriatric Medicine, Karolinska University Hospital-Huddinge, Stockholm, Sweden
- Daniela Galimberti
- Biomedical, Surgical and Dental Sciences, University of Milan, Centro Dino Ferrari, Milan, Italy; Fondazione IRCCS Ca’ Granda, Ospedale Policlinico, Neurodegenerative Diseases Unit, Milan, Italy
- Robert Laforce, Jr
- Clinique Interdisciplinaire de Mémoire, Département des Sciences Neurologiques, Université Laval, Québec, Canada
- James B Rowe
- Department of Clinical Neurosciences and Medical Research Council, Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, United Kingdom
- Elizabeth Finger
- Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada
- Rik Vandenberghe
- Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium
- Fabrizio Tagliavini
- Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Neurologica Carlo Besta, Milano, Italy
- Alexandre de Mendonça
- Faculty of Medicine, University of Lisbon, Lisbon, Portugal
- Isabel Santana
- Faculty of Medicine, University of Coimbra, Coimbra, Portugal
- Matthis Synofzik
- Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany; German Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
- Simon Ducharme
- Department of Psychiatry, McGill University Health Centre, McGill University, Montreal, Québec, Canada; McConnell Brain Imaging Centre, Montreal Neurological Institut, McGill University, Montreal, Québec, Canada
- Johannes Levin
- Department of Neurology, Ludwig-Maximilians-University, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Site Munich, Munich, Germany; SyNergy,Munich Cluster for Systems Neurology, Munich, Germany
- Adrian Danek
- Department of Neurology, Ludwig-Maximilians-University, Munich, Germany
- Alex Gerhard
- Faculty of Medical and Human Sciences, Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK
- Markus Otto
- Department of Neurology, University of Ulm, Ulm, Germany
- Chris Butler
- Department of Clinical Neurology, University of Oxford, Oxford, United Kingdom
- Giovanni Frisoni
- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy; Memory Clinic LANVIE-Laboratory of Neuroimaging of Aging, University Hospitals and University of Geneva, Geneva, Switzerland
- Sandro Sorbi
- Department of Neuroscience, Psychology, Drug Research, and Child Health, University of Florence, Florence, Italy; Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Don Carlo Gnocchi, Florence, Italy
- Carolin Heller
- Dementia Research Centre, Department of Neurodegenerative Disease, Queen Square UCL Institute of Neurology, London, UK
- Martina Bocchetta
- Dementia Research Centre, Department of Neurodegenerative Disease, Queen Square UCL Institute of Neurology, London, UK
- David M Cash
- Dementia Research Centre, Department of Neurodegenerative Disease, Queen Square UCL Institute of Neurology, London, UK
- Rhian S Convery
- Dementia Research Centre, Department of Neurodegenerative Disease, Queen Square UCL Institute of Neurology, London, UK
- Katrina M Moore
- Dementia Research Centre, Department of Neurodegenerative Disease, Queen Square UCL Institute of Neurology, London, UK
- Jonathan D Rohrer
- Dementia Research Centre, Department of Neurodegenerative Disease, Queen Square UCL Institute of Neurology, London, UK
- Raquel Sanchez-Valle
- Alzheimer’s disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain; Departament de Biomedicina, Institute of Neuroscience, University of Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain; Corresponding author at: Alzheimer’s disease and other cognitive disorders Unit, Hospital Clinic, Institut d’Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), University of Barcelona, Villarroel, 170 08036 Barcelona, Spain.
- Martin N. Rossor
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- Nick C. Fox
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- Ione O.C. Woollacott
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- Rachelle Shafei
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- Caroline Greaves
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- Mollie Neason
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- Rita Guerreiro
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- Jose Bras
- Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- David L. Thomas
- Neuroimaging Analysis Centre, Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, Queen Square, London, UK
- Jennifer Nicholas
- Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK
- Simon Mead
- MRC Prion Unit, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- Lieke Meeter
- Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands
- Jessica Panman
- Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands
- Janne Papma
- Department of Neurology, Erasmus Medical Centre, Rotterdam, Netherlands
- Rick van Minkelen
- Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, Netherlands
- Yolande Pijnenburg
- Amsterdam University Medical Centre, Amsterdam VUmc, Amsterdam, Netherlands
- Begoña Indakoetxea
- Cognitive Disorders Unit, Department of Neurology, Donostia University Hospital, San Sebastian, Gipuzkoa, Spain; Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain
- Alazne Gabilondo
- Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain
- Mikel TaintaMD
- Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain
- Maria de Arriba
- Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain
- Ana Gorostidi
- Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain
- Miren Zulaica
- Neuroscience Area, Biodonostia Health Research Institute, San Sebastian, Gipuzkoa, Spain
- Jorge Villanua
- OSATEK, University of Donostia, San Sebastian, Gipuzkoa, Spain
- Zigor Diaz
- CITA Alzheimer, San Sebastian, Gipuzkoa, Spain
- Jaume Olives
- Alzheimer’s disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d’Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain
- Albert Lladó
- Alzheimer’s disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d’Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain
- Mircea Balasa
- Alzheimer’s disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d’Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain
- Anna Antonell
- Alzheimer’s disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Clínic, Institut d’Investigacións Biomèdiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain
- Nuria Bargallo
- Imaging Diagnostic Center, Hospital Clínic, Barcelona, Spain
- Enrico Premi
- Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
- Maura Cosseddu
- Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
- Stefano Gazzina
- Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
- Alessandro Padovani
- Centre for Neurodegenerative Disorders, Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy
- Roberto Gasparotti
- Neuroradiology Unit, University of Brescia, Brescia, Italy
- Silvana Archetti
- Biotechnology Laboratory, Department of Diagnostics, Spedali Civili Hospital, Brescia, Italy
- Sandra Black
- Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada
- Sara Mitchell
- Sunnybrook Health Sciences Centre, Sunnybrook Research Institute, University of Toronto, Toronto, Canada
- Ekaterina Rogaeva
- Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Canada
- Morris Freedman
- Baycrest Health Sciences, Rotman Research Institute, University of Toronto, Toronto, Canada
- Ron Keren
- The University Health Network, Toronto Rehabilitation Institute, Toronto, Canada
- David Tang-Wai
- The University Health Network, Krembil Research Institute, Toronto, Canada
- Linn Öijerstedt
- Department of Geriatric Medicine, Karolinska University, Hospital-Huddinge, Stockholm, Sweden
- Christin Andersson
- Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- Vesna Jelic
- Division of Clinical Geriatrics, Karolinska Institutet, Stockholm, Sweden
- Hakan Thonberg
- Center for Alzheimer, Research, Divison of Neurogeriatrics, Karolinska Institutet, Stockholm, Sweden
- Andrea Arighi
- Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- Chiara Fenoglio
- Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- Elio Scarpini MD
- Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Neurodegenerative Diseases Unit, Milan, Italy; Dementia Research Centre, Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London, UK
- Giorgio Fumagalli
- University of Milan, Centro Dino, Ferrari, Milan, Italy; Department of Neurosciences, Psychology, Drug Research and Child Health, (NEUROFARBA), University of Florence, Florence, Italy; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
- Thomas Cope
- Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
- Carolyn Timberlake
- Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
- Timothy Rittman
- Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK
- Christen Shoesmith
- Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada
- Robart Bartha
- Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada; Department of Medical Biophysics, The University of Western Ontario, London, Ontario, Canada
- Rosa Rademakers
- Centre for Functional and Metabolic Mapping, Robarts Research Institute, The University of Western Ontario, London, Ontario, Canada
- Carlo Wilke
- Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA; Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research and Center of Neurology, University of Tübingen, Tübingen, Germany
- Benjamin Bender
- Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany
- Rose Bruffaerts
- Department of Diagnostic and Interventional Neuroradiology, University of Tübingen, Tübingen, Germany
- Philip Vandamme
- Laboratory for Cognitive Neurology, Department of Neurosciences, KU Leuven, Leuven, Belgium
- Mathieu Vandenbulcke
- Neurology Service, University Hospitals Leuven, Belgium, Laboratory for Neurobiology, VIB-KU Leuven Centre for Brain Research, Leuven, Belgium; Geriatric Psychiatry Service, University Hospitals Leuven, Belgium
- Carolina Maruta
- Neuropsychiatry, Department of Neurosciences, KU Leuven, Leuven, Belgium
- Catarina B. Ferreira
- Laboratory of Neurosciences, Institute of Molecular Medicine, Faculty of Medicine, University of Lisbon, Lisbon, Portugal
- Gabriel Miltenberger
- Faculty of Medicine, University of Lisbon, Lisbon, Portugal
- Ana Verdelho
- Department of Neurosciences and Mental Health, Centro Hospitalar Lisboa, Norte - Hospital de Santa Maria & Faculty of Medicine, University of Lisbon, Lisbon, Portugal
- Sónia Afonso
- Instituto Ciencias, Nucleares Aplicadas a Saude, Universidade de Coimbra, Coimbra, Portugal
- Ricardo Taipa
- Neuropathology Unit and Department, of Neurology, Centro Hospitalar do Porto - Hospital de Santo António, Oporto, Portugal
- Paola Caroppo
- Fondazione IRCCS Istituto, Neurologico Carlo Besta, Milano, Italy
- Giuseppe Di Fede
- Fondazione IRCCS Istituto, Neurologico Carlo Besta, Milano, Italy
- Giorgio Giaccone
- Fondazione IRCCS Istituto, Neurologico Carlo Besta, Milano, Italy
- Sara Prioni
- Fondazione IRCCS Istituto, Neurologico Carlo Besta, Milano, Italy
- Veronica Redaelli
- Fondazione IRCCS Istituto, Neurologico Carlo Besta, Milano, Italy
- Giacomina Rossi
- Fondazione IRCCS Istituto, Neurologico Carlo Besta, Milano, Italy
- Pietro Tiraboschi
- Fondazione IRCCS Istituto, Neurologico Carlo Besta, Milano, Italy
- Diana Duro
- Faculty of Medicine, University of Coimbra, Coimbra, Portugal
- Maria Rosario Almeida
- Faculty of Medicine, University of Coimbra, Coimbra, Portugal
- Miguel Castelo-Branco
- Faculty of Medicine, University of Coimbra, Coimbra, Portugal
- Maria João Leitão
- Centre of, Neurosciences and Cell biology, Universidade de Coimbra, Coimbra, Portugal
- Miguel Tabuas-Pereira
- Neurology Department, Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal
- Beatriz Santiago
- Neurology Department, Centro Hospitalar e Universitario de Coimbra, Coimbra, Portugal
- Serge Gauthier
- Alzheimer Disease Research Unit, McGill Centre for Studies in Aging, Department of Neurology & Neurosurgery, McGill University, Montreal, Québec, Canada
- Pedro Rosa-Neto
- Translational Neuroimaging Laboratory, McGill Centre for Studies in Aging, McGill University, Montreal, Québec, Canada
- Michele Veldsman
- 58Nuffield Department of Clinical Neurosciences, Medical Sciences Division, University of Oxford, Oxford, UK
- Toby Flanagan
- Faculty of Biology, Medicine and Health, Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK
- Catharina Prix
- Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany
- Tobias Hoegen
- Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany
- Elisabeth Wlasich
- Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany
- Sandra Loosli
- Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany
- Sonja Schonecker
- Neurologische Klinik, Ludwig-Maximilians-Universität München, Munich, Germany
- Elisa Semler
- Department of Neurology, University of Ulm, Ulm, Germany
- Sarah Anderl-Straub
- Department of Neurology, University of Ulm, Ulm, Germany
- Journal volume & issue
-
Vol. 29
p. 102540
Abstract
Mutations in the granulin gene (GRN) cause familial frontotemporal dementia. Understanding the structural brain changes in presymptomatic GRN carriers would enforce the use of neuroimaging biomarkers for early diagnosis and monitoring. We studied 100 presymptomatic GRN mutation carriers and 94 noncarriers from the Genetic Frontotemporal dementia initiative (GENFI), with MRI structural images. We analyzed 3T MRI structural images using the FreeSurfer pipeline to calculate the whole brain cortical thickness (CTh) for each subject. We also perform a vertex-wise general linear model to assess differences between groups in the relationship between CTh and diverse covariables as gender, age, the estimated years to onset and education. We also explored differences according to TMEM106B genotype, a possible disease modifier. Whole brain CTh did not differ between carriers and noncarriers. Both groups showed age-related cortical thinning. The group-by-age interaction analysis showed that this age-related cortical thinning was significantly greater in GRN carriers in the left superior frontal cortex. TMEM106B did not significantly influence the age-related cortical thinning. Our results validate and expand previous findings suggesting an increased CTh loss associated with age and estimated proximity to symptoms onset in GRN carriers, even before the disease onset.